- Home
- FRBA vs CRVS Comparison
FRBA vs CRVS Comparison
Compare FRBA & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRBA
- CRVS
- Stock Information
- Founded
- FRBA 2007
- CRVS 2014
- Country
- FRBA United States
- CRVS United States
- Employees
- FRBA N/A
- CRVS N/A
- Industry
- FRBA Major Banks
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- FRBA Finance
- CRVS Health Care
- Exchange
- FRBA Nasdaq
- CRVS Nasdaq
- Market Cap
- FRBA 364.6M
- CRVS 305.4M
- IPO Year
- FRBA N/A
- CRVS 2016
- Fundamental
- Price
- FRBA $16.72
- CRVS $5.50
- Analyst Decision
- FRBA Strong Buy
- CRVS Strong Buy
- Analyst Count
- FRBA 2
- CRVS 4
- Target Price
- FRBA $18.00
- CRVS $15.00
- AVG Volume (30 Days)
- FRBA 49.9K
- CRVS 499.6K
- Earning Date
- FRBA 10-22-2025
- CRVS 08-07-2025
- Dividend Yield
- FRBA 1.44%
- CRVS N/A
- EPS Growth
- FRBA 22.16
- CRVS N/A
- EPS
- FRBA 1.51
- CRVS N/A
- Revenue
- FRBA $131,202,000.00
- CRVS N/A
- Revenue This Year
- FRBA $12.28
- CRVS N/A
- Revenue Next Year
- FRBA $6.37
- CRVS N/A
- P/E Ratio
- FRBA $11.06
- CRVS N/A
- Revenue Growth
- FRBA 14.51
- CRVS N/A
- 52 Week Low
- FRBA $12.74
- CRVS $2.54
- 52 Week High
- FRBA $16.89
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- FRBA 71.09
- CRVS 66.45
- Support Level
- FRBA $16.32
- CRVS $5.03
- Resistance Level
- FRBA $16.78
- CRVS $5.64
- Average True Range (ATR)
- FRBA 0.35
- CRVS 0.32
- MACD
- FRBA 0.12
- CRVS 0.06
- Stochastic Oscillator
- FRBA 92.12
- CRVS 81.36
About FRBA First Bank
First Bank is a full-service commercial bank, with target businesses from individuals, businesses, and governmental entities located in service regions throughout New Jersey and eastern Pennsylvania, with a particular focus between New York City and Philadelphia. The group focuses on traditional deposit and loan products with businesses and individuals living and working in markets as the source of businesses. Its services are Business Banking; Personal banking; Digital Banking; and Lending.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).